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Abstract
Genetic polymorphisms can shape the global landscape of DNA methylation, by either changing substrates for DNA
methyltransferases or altering the DNA binding affinity of cis-regulatory proteins. The interactions between CpG
methylation and genetic polymorphisms have been previously investigated by methylation quantitative trait loci (mQTL)
and allele-specific methylation (ASM) analysis. However, it remains unclear whether these approaches can effectively and
comprehensively identify all genetic variants that contribute to the inter-individual variation of DNA methylation levels.
Here we used three independent approaches to systematically investigate the influence of genetic polymorphisms on
variability in DNA methylation by characterizing the methylation state of 96 whole blood samples in 52 parent-child trios
from 22 nuclear pedigrees. We performed targeted bisulfite sequencing with padlock probes to quantify the absolute DNA
methylation levels at a set of 411,800 CpG sites in the human genome. With mid-parent offspring analysis (MPO), we
identified 10,593 CpG sites that exhibited heritable methylation patterns, among which 70.1% were SNPs directly present in
methylated CpG dinucleotides. We determined the mQTL analysis identified 49.9% of heritable CpG sites for which
regulation occurred in a distal cis-regulatory manner, and that ASM analysis was only able to identify 5%. Finally, we
identified hundreds of clusters in the human genome for which the degree of variation of CpG methylation, as opposed to
whether or not CpG sites were methylated, was associated with genetic polymorphisms, supporting a recent hypothesis on
the genetic influence of phenotypic plasticity. These results show that cis-regulatory SNPs identified by mQTL do not
comprise the full extent of heritable CpG methylation, and that ASM appears overall unreliable. Overall, the extent of
genome-methylome interactions is well beyond what is detectible with the commonly used mQTL and ASM approaches,
and is likely to include effects on plasticity.
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Introduction
DNA methylation represents an important layer of epigenetic
regulation on the transcriptional activity of the human genome
and plays a crucial role in genomic imprinting, embryonic
development and determination of cell type. Accumulating
evidence suggests that DNA methylation patterns, rather than
being similar within members of the same species, vary from one
individual to another [1,2,3] due to both genetic and environ-
mental factors [4,5]. This variability could potentially explain why
certain phenotypic outcomes manifest differently across individu-
als of the same species, including in terms of the susceptibility to
and treatability of many human diseases [6,7].
With the recent advances in DNA methylation assays, a growing
number of studies have identified a genetic contribution to inter-
individual variation in DNA methylomes. One type of study relies
on methylation quantitative trait locus (mQTL) mapping, which
identifies genomic polymorphisms associated with variation of
CpG methylation in a cis-regulatory manner [8,9,10,11]. An
alternative approach involves characterizing allele-specific meth-
ylation, in which a change in a specific polymorphism leads to the
direct loss or gain of DNA methylation [2,3,12,13,14,15]. While
an increasingly large number of associations between SNPs and
CpG sites have been reported in these recent efforts, it remains
unclear whether mQTL and ASM analyses are truly uncovering
the full extent of genome-methylome interactions. In this study, we
performed targeted bisulfite sequencing on human whole blood
samples from 96 individuals representing 22 nuclear pedigrees,
and took advantage of the parent-child trios using mid-parent
offspring (MPO) analysis to fully uncover genome-methylome
interactions. We then performed mQTL and ASM analysis on the
same samples, and investigated the capability of each method to
identify the genetic contribution to inter-sample methylation
variability.
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Results
We characterized DNA methylation levels in genomic DNA
from the peripheral blood of 96 individuals in 22 nuclear pedigrees
of European ancestry, each including one proband with schizo-
phrenia, two unaffected parents and one or two unaffected siblings
(a total of 52 trios of two parents and one child). We measured
CpG methylation at single base resolution using ,330,000
bisulfite padlock probes capturing a pre-selected subset of genomic
regions, including promoters, enhancers, DNase I hypersensitive
sites and other regions known to be variable among different cell
types [16]. Note that, like other bisulfite-based methods, 5-
methylcytosine and 5-hydroxymethylcytosine are indistinguishable
with this assay. In addition, several recent works have shown that
variation in cell composition is a confounding factor [17,18,19]. In
this study, we did not correct for cell composition due to the lack of
reference data from pure cell populations, and treated the average
methylation of all cells in whole blood as a quantitative trait. On
average, we obtained methylation measurements for ,500,000
CpG sites per sample. A total of 411,800 autosomal CpG sites (and
5,133 on sex chromosomes) had valid methylation measurements
in at least 80% of samples. We filtered out CpG sites showing low
variability among samples (‘‘static CpG sites’’), and focused all
further analysis on a subset of 76,408 autosomal variable CpG sites
(those with standard deviation of methylation levels across all
samples $0.1). Hierarchical clustering based on the methylation
levels of highly variable autosomal CpG sites (standard deviation
$0.3) showed a clustering pattern consistent with the family
structure (Figure S1 in File S1). While several samples came from
individuals with schizophrenia, the sample size here was too small
to perform any significant association tests between disease state
and either genetic or methylation factors; thus, we focused on
treating methylation itself as a quantitative trait and investigating
its relation to individual genetic variants.
MPO identifies CpG sites known to have heritable
methylation patterns using trio information
In order to obtain an independent list of CpG sites where
variability in DNA methylation was known to be related to genetic
factors, we performed mid-parent offspring (MPO) analysis [20],
which analyzes the correlation between the mean methylation
level at each CpG site in each parent pair and the methylation
level at the same CpG sites in the child (Figure 1a). This family-
based analysis of each trio allowed identification of any potential
heritable methylation patterns irrespective of the type and
frequency of genetic variants (i.e. SNPs, indels, structural genomic
variation) or the method of regulation. We identified CpG sites as
heritable by requiring a heritability (h2) value greater than 0.2 in a
minimum of available data in ten trios with a FDR cutoff of 0.05
(with Benjamini-Hochberg correction).
We identified a total of 10,593 CpG sites that possessed variable
methylation directly correlated with genetic pedigree (Table S1),
accounting for ,13.9% of all variable CpG sites. This result
suggests, based on the samples in this study, that genetic factors
account for over ten percent of inter-sample DNA methylation
variability in human blood. Further analysis revealed that 70%
(7,424) of these CpG sites in fact showed variable methylation due
to their containing a family-specific SNP at exactly the same locus.
This result indicates that the majority of heritable CpG
methylation patterns are due to genetic polymorphisms directly
altering the substrates of DNA methyltransferases (‘‘SNP-CpGs’’),
whereas other cis- or trans- regulatory effects account for only a
small fraction (3,169, ,30%) of heritable CpG methylation (‘‘non-
SNP CpGs’’) (Figure 2a). Non-SNP CpG sites that localized close
by appeared to share similar methylation patterns within
individuals of the same family, suggesting that one genetic variant
or haplotype could be affecting multiple CpG sites (Table S2,
Figure 1b-c). Heritable CpG sites were not enriched for any
particular genomic region, as they showed a similar distribution
across the genome as all variable CpG sites (Table S3). However,
moderate enrichment in gene body and intergenic regions was
observed over all characterized CpGs. (Table S3)
mQTL finds associations between SNPs and CpG sites in a
population without trio information
While it is possible to identify heritability in DNA methylation
through MPO analysis, for a majority of cases, parent-child trio
data is unavailable. In order to determine what fraction of
genome-methylome interactions could be identified at a popula-
tion level when pedigree information was not present, we treated
each CpG site as a methylation quantitative trait locus (mQTL),
and analyzed the effects on methylation levels of common SNPs or
other genetic variants in linkage disequilibrium (LD) with the
index SNPs. We sought to perform an analysis using SNP
genotypes determined by multiple platforms in order to identify
the optimal strategy for identifying genomic contributions to
methylation. In some cases, performing additional experiments to
obtain sample genotypes is cost-prohibitive; we therefore first
utilized the bisulfite sequencing data itself to call genomic SNPs
using a previously described method [16]. We obtained genotypes
at 15,450 SNP sites after requiring genotypes to be called at
putative SNP sites in at least 75% of subjects. Because these SNPs
were called only in the captured regions, SNP density was low
compared to the whole genome. In order to also perform a more
comprehensive mQTL mapping using additional SNPs, we
derived SNPs of 57 subjects, a subset of the 96 samples passing
quality control of SNP genotyping, using both Affymetrix and
Illumina SNP arrays. To avoid platform-specific technical
differences, we performed imputation using SNP data from the
1,000 Genomes Project [21], and obtained genotypes for ,5
million SNPs per sample.
Figure 1. Identification of heritable CpG methylation by mid-
parent offspring (MPO) analysis. (a) An example of mid-parent
offspring regression of DNA methylation at the CpG site
chr1:146549909. (b,c) DNA methylation level of heritable CpG at
chr1:146549909 and the adjacent heritable CpGs on the same cluster
exhibiting consistent pattern of DNA methylation between parents and
their offspring on the two trios from the same family.
doi:10.1371/journal.pone.0099313.g001
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We performed mQTL regression analysis using PLINK with
QFAM familial dependence correction [22] between the DNA
methylation level of each variable CpG site and the genotypes of
SNPs located up to 1 Mb upstream and downstream. Using SNP
calls from the bisulfite sequencing data, we identified 7,593 CpG-
SNP cis-associations at ,5% FDR (Table S4), consisting of 4,253
CpG sites associated with 3,842 SNPs. With the ,5 million
genome-wide SNPs, we identified a total of 644,773 CpG-SNP cis-
associations at ,5% FDR (Table S5), consisting of 9,783 CpGs
associated with 412,382 SNPs. As in the MPO analysis, a majority
of CpG-SNP interactions were due to genetic mutations directly at
the CpG site (66.7% and 70.5%, respectively, Figure 2b, 2c).
Generally, the majority of cis-regulatory SNPs were located very
close to their associated CpG sites in both SNP data sets. For the
SNPs called from bisulfite sequencing reads, 47.6% of the CpG-
SNP associations were within 2 kb (Table S6, Figure S2a in File
S1), and only 15.2% of associations were further away than 100 kb
(Table S6, Figure S2b, S2e in File S1). For the SNPs called using
genome-wide arrays that more uniformly capture the LD blocks in
the human genome, over 64.9% of CpG-SNP associations were
within 100 kb (Table S7, Figure S2f in File S1), with the strongest
associations mostly within 2 kb (Table S7, Figure S2c in File S1).
The identified additional enrichment of short-range CpG-SNP
associations in the bisulfite sequencing SNP data appeared to be
partially due to sampling bias, because SNPs were called only in
captured regions and thus tended to locate very close to CpG sites
(Figure S2a, S2e in File S1); it appears that to fully characterize
long-range CpG-SNP interactions, SNP genotyping is required.
However, bisREAD SNPs can be called directly from methylation
sequencing data, whereas SNP genotyping experiments involve
extra experimental cost. Additionally, even though the number of
bisREAD SNPs used in our analysis was ,340 fold less than the
genome-wide SNPs, it was still possible to identify half of the long-
distance non-SNP CpG interactions. Therefore, in cases where
SNP genotyping experiments are difficult to perform due to either
limited biological material or budgetary constraints, SNPs called
from bisulfite sequencing data can still be used to capture a
reasonable fraction of cis-regulatory interactions, with the caveat
that long distance interactions will be under-represented.
Finally, in order to ensure that CpG-SNP interactions were not
being missed due to excessive penalties from multiple testing
correction in the 5 million SNP case, we additionally performed
mQTL analysis using a subset containing 618,580 SNPs in unique
LD blocks. The number of CpG-SNP associations decreased to
Figure 2. Fraction of non-SNP CpGs and SNP-CpG identified in MPO, mQTL, and ASM analysis. (a) Pie chart showing the number of
heritable non-SNP CpGs and heritable SNP-CpGs. (b, c) Pie charts showing the fraction of mQTL associated non-SNP CpG and SNP-CpGs from mQTL
analysis using bisREAD SNP data and 5 M imputed SNP array data, respectively. (d) Pie chart showing the fraction of non-SNP CpG ASM and SNP-CpG
ASM exist in at least one subject.
doi:10.1371/journal.pone.0099313.g002
Genome-Methylome Interactions in Nuclear Pedigrees
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e99313
67,781 (at FDR ,5%), indicating that multiple testing penalties
were not having a large impact on statistical testing in this case (as
a similar fraction of CpG-SNP interactions out of total putative
interactions were identified as true in each case).
ASM finds associations between SNPs and CpGs in single
samples
We next used a third strategy to examine the attempt to discern
the influence of genetic variation on DNA methylation levels by
analyzing allele-specific methylation (ASM). Unlike the MPO and
mQTL analysis methods, which utilize information from multiple
samples together, ASM examines genome-methylome interactions
in one sample at a time. Using this recently developed
computational procedure [13], we identified an average of 2,266
variable CpG sites per individual that exhibited significant
difference in allelic methylation based on genomic factors
(methylation difference .0.2). Consistent with previous observa-
tions [12,13,23], most ASM events were due to SNPs present
directly at CpG sites, (69.7%–92.5%, average 86.4%), with non-
SNP CpG sites representing a very small fraction of putative
genome-methylome interaction (Figure S3a, S3b in File S1).
Additionally, the majority of detected ASM events were present in
only a small fraction of subjects (Table S8). After combining all
overlapping ASM events, we identified 10,927 and 14,809 ASM
events at non-SNP CpGs and SNP-CpGs respectively (Figure 2d).
We observed a modest enrichment of ASM on non-SNP CpGs in
gene body and intergenic regions (Table S9, Figure S3c, S3d in
File S1).
The efficacy of mQTL and ASM in identifying genome-
methylome interaction
While the genomic cis-regulated CpG sites identified by MPO
appear to be truly heritable through the use of trio information, it
remained unclear to what extent mQTL and ASM analyses were
characterizing true genome-methylome interactions. We thus next
compared the three analyses to determine the efficacy of mQTL
and ASM analysis.
While, as expected, most SNP-CpG sites identified by mQTL
were true positive sites showing heritable CpG methylation
(85.3%, Figure S4a in File S1), surprisingly, only 49.9% of non-
SNP CpGs identified by mQTL analysis were found heritable by
MPO analysis (Figure 3a), indicating that only half of non-SNP
CpG sites identified by mQTL mapping are truly heritable.
mQTL also failed to identify 54.6% of true heritable non-SNP
CpGs (Figure 3a), indicating that for non-SNP CpGs, in addition
to having a high false positive rate, mQTL analysis also appears to
have a high false negative rate as well. This discrepancy could be
due to a number of reasons, including lack of statistical power due
to limited sample size, presence of long-range cis-interactions at a
distance of over 1 megabase and/or trans-interactions [24], and the
effects of other common or rare alleles not in LD with the SNPs
tested. In addition, some marginally significant sites might be
included or excluded due to the specific choices of p-value cut-offs
for each of the two methods. In fact, when we plotted the mQTL
association signals for heritable and non-heritable CpG sites
separately, the majority of CpGs most strongly associated with
SNPs (low p-value) were heritable CpGs (Figure 3b, Figure S4b in
File S1). Non-heritable CpGs in general showed weaker associa-
tion signals, especially for longer-range cis-interactions (Figure 3c,
Figure S4c in File S1). It is possible that heritable CpG sites not
identified by mQTL analysis could be regulated by other genetic
mechanisms.
In contrast to the mQTL analysis, only very small fractions of
CpG sites that seemed to exhibit ASM in at least one sample were
found to be heritable (5.6% for non-SNP CpGs, 32.6% for SNP-
CpGs) (Table S8). One possibility is that calls made by ASM
contain a high number of false positive CpG-SNP interactions.
However, when we restricted our analysis to the CpG sites that
exhibited consistent ASM patterns in two or more individuals, the
fractions of sites overlapping with heritable CpGs increased only
moderately, and remained far from the 49.9% or 85.3% overlap
observed between mQTL calls and heritable CpGs. These calls
could be explained by a number of possibilities, including non-
genetic parent-of-origin effects (including but not limited to
imprinting), random allelic drift [25], environmental factors,
potentially higher false positive rates, or higher sensitivity than
MPO in detecting allelic differences. Overall, however, ASM
appears to have very low specificity in identifying CpG sites
regulated by genetic variants.
Genetic polymorphisms affect the degree of variability in
DNA methylation
Recently, it was proposed that genetic variants might be
regulating the level of variability in molecular phenotypes such as
CpG methylation rather than just regulating the exact methylation
state [26,27]. Under this hypothesis, a particular allele of a SNP is
associated with highly variable methylation patterns across
multiple individuals (Figure 4b) as opposed to being associated
with a consistent increase or decrease in mean methylation level
(Figure 4a). To determine if variation-SNPs (vSNPs) were present
in this data set, we performed a regression analysis on the variance
of DNA methylation at each CpG site and the genotypes of nearby
SNPs (within 1 Mb). A major technical challenge is that there are
only three genotypes for each SNP, and hence the sample size for
each regression is limited to three; this could potentially result in a
very high false positive rate. To counteract this, we required that a
candidate vSNP had a consistent effect on at least five adjacent
CpG sites. The false positive rate was estimated to be ,10% by
applying the same procedure to randomly permuted methylation
data.
A total of 1,058 genomically-linked variably methylated regions
(VMRs) were identified, with many SNPs associated with the
variance of multiple nearby CpG sites (Table S10, Figure 4a, 4b).
These nearby sites were further grouped into 383 VMR clusters
(Table S11) by combining multiple VMRs that were within
100 kb. The majority of VMR clusters (316 clusters, 82.5%) were
located within 1 Mb of a set of 438 genes. The largest VMR
cluster involved 53 variable CpG sites in a 38 kb region covering
GNAS, which is a well documented imprinted gene that has a
highly complex expression pattern from both strands [28,29]. Two
other large VMR clusters overlapped with the HoxA gene cluster
and protocadherin gamma gene cluster, both of which contain
multiple functionally related and co-regulated genes and pseudo-
genes.
While the full functional consequences of such variable
methylation remain largely unknown, we note that very recently
four SNPs were found to be associated with rheumatoid arthritis
and variance of methylation [18]. In order to test whether the
observed VMR clusters could translate into genotype-specific
variation at the gene expression level, we examined the top 10
VMR clusters and their respective genes in an array-based whole
blood gene expression data set of 240 independent subjects [30].
Nine of the genes within the top ten VMR clusters were expressed
at detectable levels (Table 1). Even though the effect sizes were
small, we observed three genes (GNAS, PEG3, and PCDHGA5)
Genome-Methylome Interactions in Nuclear Pedigrees
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from different VMR clusters all showing genotype-specific
differences contributing to variance at the gene expression level.
Discussion
In the recent years, association mapping of molecular pheno-
types such as gene expression, DNA methylation, or chromatin
accessibility as quantitative traits (eQTL, mQTL, dsQTL) has
revealed how genetic variants contribute to inter-individual
variability and provided additional insights into the modulation
of disease susceptibility [1,20,31,32,33,34]. The recent technical
advances in low-cost genome-wide DNA methylation assays (such
as the Illumina 450 k methylation array [35], RRBS [36], and
BSPP [16]) have catalyzed a new wave of epigenome-wide
association studies aiming to characterize the contribution of both
genetic and environmental factors to disease susceptibility [4,37],
with encouraging progress already in sight [18,38,39,40]. Howev-
er, while new analysis techniques have connected genetic variants,
CpG methylation, and disease phenotypes, it remains unclear to
what extent we should expect interaction to occur between genetic
variation and the variability of DNA methylation, what fraction of
interactions are able to be captured with current approaches, and
what strategy we should use to efficiently capture these interac-
tions.
In this study, we revealed that a large extent of genome-
methylome interaction is completely missed by current analysis
methods. By comparing the results from mQTL analysis to MPO
analysis, which is guaranteed to find heritable methylation
patterns, in 22 nuclear pedigrees, we demonstrated that a large
fraction of heritable traits affecting CpG methylation remain hard
or impossible to detect with the most widely used analysis method.
However, we hypothesize that trans-regulation might account for
Figure 3. Mapping of CpG sites identified in MPO and mQTL analyses. (a) Venn diagrams showing overlap between non-SNP CpG sites
significant in mQTL on 5,257,772 imputed SNPs and heritable CpGs. (b, c) Distribution of heritable CpGs and non-heritable CpGs and associated SNP
pair distance within 500kb and their corresponding p-values from mQTL analysis on imputed SNPs.
doi:10.1371/journal.pone.0099313.g003
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the majority of heritable CpG sites not detectible by conventional
mQTL analysis. While the anti-correlation of promoter DNA
methylation and gene expression has been observed for many
years, the exact mechanistic explanation behind DNA methylation
regulating gene expression has yet to be firmly established. More
recent observations of positive correlation between gene-body
methylation and gene expression have added additional confusion
to the functional role of DNA methylation [41,42,43,44]. Stadler
et al. recently demonstrated that binding of protein factors to DNA
can lead to local reduction of DNA methylation [45], providing
the first direct evidence that DNA methylation in general is a
passive mark for protein-DNA binding. A corollary of this
observation is that a DNA binding protein (such as a transcription
factor) for which the expression is an eQTL (i.e. regulated by a
genetic variant) can affect DNA methylation levels in hundreds to
thousands of its binding regions genome-wide. As such, a single
functional variant might regulate many mQTLs, mostly in trans,
mediated by its primary effect on a single transcription factor.
Connecting these mQTLs to functional variants therefore cannot
be accomplished by simple association tests using nearby CpGs
and SNPs. Additional information on the transcriptional factors
and their direct regulating genes would be required, such as that
becoming increasingly available through large-scale ChIP-Seq and
DHS mapping efforts like the ENCODE project [46]. A coherent
statistical framework for association testing that incorporates the
information of protein-DNA binding from genome-wide assays
would also be necessary to fully explore genome-methylome
interactions.
We also provided a practical assessment on the sensitivity of
mQTL mapping at various SNP densities, showing that using over
a large number of SNPs can improve the level of statistical
significance with diminishing gains in detecting additional SNP-
associated CpG sites. On the other hand, for projects based on
bisulfite sequencing, the SNP genotypes called from the sequenc-
ing reads alone can be used to recover a reasonable fraction of
associated CpG sites. As bisulfite sequencing is being widely
adopted and algorithms for SNP calling from bisulfite data are
being optimized [47], using the smaller number of obtained SNPs
could represent an economical option for large-scale EWAS
studies, with the understanding that a denser SNP map would still
be necessary to recover the majority of long-range regulatory
effects.
We additionally characterized the ability of ASM to identify
heritable methylation patterns. While we found many CpG sites
that both exhibited allele-specific methylation in different individ-
uals and showed heritable methylation patterns across all the
pedigrees, the majority of CpG sites identified in our ASM analysis
could not be explained by consistent effects of cis-regulatory
variants across multiple individuals. We reason that ASM analysis
is more susceptible to many non-genetic factors, including parent-
of-origin effects, random allelic drift, and technical artifacts, and
hence might not be appropriate as a primary approach for
identifying methylation traits regulated by genetic variants.
Population level analysis such as mQTL or MPO (if trio
information is available) appears to be necessary to accurately
characterize genomic effects on methylation patterns.
Finally, we provide evidence supporting a recently proposed
hypothesis that genetic variants can regulate not only the mean but
also the variation of molecular phenotypes such as CpG
methylation or gene expression. This is not unexpected, as gene
regulatory networks are connected through both positive and
negative feedback [48,49]. Reduction of negative feedback has
been shown to increase the variability in both prokaryotic and
eukaryotic organisms [50,51], lending mechanistic support to the
idea that genetic variants affecting the strength of negative
regulation could result in a difference in variability for the
components involved in a molecular network. Feinberg and
colleagues have proposed that epigenetic variability provides a
mechanism for selectable phenotypic variation [27], and provided
examples of variable DNA methylation and its role in cancer [26]
and rheumatoid arthritis [18]. Although the full extent of variable
DNA methylation, as well as its phenotypic consequences, remain
to be further characterized with larger cohorts of genetically
unrelated individuals, the observation of hundreds of VMRs in the
22 nuclear pedigrees analyzed here suggests that the inherent
variability of CpG methylation, and possibly other molecular
phenotypes, is likely to play a broad role in human biology and
disease.
Materials and Methods
Sample collection
Genomic DNAs from the 96 individuals of 22 pedigrees were
extracted from whole blood previously collected as part of an on-
going genetic study of schizophrenia under the IRB approvals by
Utrecht and UCLA. Written consents were obtained from all
donors. All personal identifiers were removed and replaced by
alpha numerical codes for sample tracking. The information that is
available to us as researchers include age, gender and family
relationships.
Targeted bisulfite sequencing with padlock probes
Bisulfite padlock probe design, production and sequencing were
previously described [16,43]. Briefly, genomic DNA was extracted
from peripheral blood of 22 pedigrees, and approximately 1 mg of
genomic DNA was bisulfite converted with EZ-96 Zymo DNA
Methylation-Gold kit (Zymo Research). Approximately 250 ng of
bisulfite converted genomic DNAs were mixed with normalized
amount of genome-wide scale padlock probes and oligo suppres-
sors. The padlock probes were annealed to bisulfite converted
genomic DNA. The gap between two ends of padlock probes was
filled and ligated with AmpliTaq DNA polymerase, Stoffel
fragment (Life Technologies) and Ampligase (Epicentre), respec-
tively resulting in circularized DNA. The bisulfite sequencing
Figure 4. Genotype effects on the mean and variance of DNA
methylation (a) Heatmap and line plot showing the association
between rs4950357 SNP and the mean methylation of
heritable CpGs cluster on chromosome 1 (chr1: 146548425-
146555855). (b) The association of rs2833839 vSNP and the variance
of methylation on VMR (chr21:34405506-34405661).
doi:10.1371/journal.pone.0099313.g004
Genome-Methylome Interactions in Nuclear Pedigrees
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e99313
libraries were generated by library-free BSPP protocol as described
[16]. Briefly, two-thirds of the circularized DNA of each captured
reaction were directly amplified and barcoded with adapter primers
compatible with Illumina sequencer. The bisulfite sequencing
libraries were purified with AMPure XPmagnetic beads (Agencourt),
pooled in equimolar ratios, size selected at the size approximately
375 bp with 6% TBE polyacrylamide gel (Life Technologies), and
sequenced by Illumina HiSeq2000 and GAIIx sequencers.
DNA methylation data
The pooled libraries were firstly sequenced with Illumina
HiSeq2000 sequencer (100 bp, paired-end reads). Additional
sequencings were performed for those samples with number of
reads less than 22 millions (53 samples) on the same sequencing
libraries with Illumina HiSeq2000 and GAIIx sequencers. Bisulfite
sequencing data were processed as described [13,16]. Briefly,
adapter sequences (27 bp from 59 end) were trimmed from
bisulfite reads prior to mapping. In bisulfite sequencing reads, all
cytosines were replaced by thymines and mapped to the in silico
bisulfite converted human genome sequences (hg19) with all
cytosines converted to thymines on both strands by bisReadMap-
per [16]. Absolute DNA methylation level at each CpG site with
minimum 106 depth coverage in each sample was calculated at
level from 0–1. Summary statistics for sequencing read mapping
for all samples sample were reported in Table S12. The quality of
the data was assessed by comparing DNA methylation levels at the
same CpG sites captured and measured independently on the two
strands, which can be treated as internal technical replicates.
Mid-parent offspring analysis
Mid-parent offspring (MPO) analysis was performed by mid-
parent offspring regression [20] to estimate the heritability of DNA
methylation at each CpG site. DNA methylation level of the
offspring in each trio was compared against the mean DNA
methylation level of the parents. In total, 76,408 autosomal
variable CpGs (minimum standard deviation of 0.1) shared in at
least 80% of subjects were analyzed. The slope of the fitted line
was used to estimate the heritability (h2) of each CpG site. CpG
sites with h2 greater than 0.2 in a minimum sample size (number of
trio) of 10 were defined as heritable CpGs. The Benjamini-
Hochberg method was used to correct for multiple testing errors.
Methylation quantitative trait loci
Methylation quantitative trait loci (mQTL) analysis was
performed by PLINK [22] to determine the association between
DNA methylation level of variable CpG sites as described above
and SNP genotypes called from methylation data (15,450 SNPs) of
96 subjects or imputed autosomal SNP genotypes (5,257,772
SNPs) of 57 subjects generated by Illumina SNP array (550K) and
Affymetrix SNP array. SNP genotypes with a minor allele
frequency (MAF) of at least 0.05 and with a Hardy-Weinberg
Equilibrium (HWE) p-value .0.001 were included in this analysis.
Mendel error rates in each nuclear family with the full trio were
calculated by PLINK (Table S13) We used least square linear
regression, and the corresponding p-values were calculated for
each CpG-SNP association pair within 1 Mb. FDR was calculated
by Benjamini-Hochberg multiple correction method to assess the
significance of the CpG-SNP association. To deal with family
structure, QFAM analysis was performed. 10,000 permutations
were performed and p-value was empirically calculated as the
fraction of permuted data test-statistic is larger than the non-
permuted data test statistic. Additional analyses were performed
on subsets of imputed SNPs including 618,580 index SNPs present
on Illumina 1 M SNP array. The SNPs that showed strong
correlation with DNA methylation were extracted and annotated
significant QTL as cis if the SNP lay within 1 Mbs of the CpG site.
SNP imputation
Array genotype data of 96 subjects of this study were generated
on two different array platforms, 23 individuals on Illumina SNP
array (550K) and 73 individuals on Affymetrix SNP array by
Wellcome Trust Case Control Consortium 2 (WTCCC2). After
removing poor quality genotyping, there were SNP data of 57
subjects in this study (11 individuals on Illumina SNP array and 46
individual on Affymetrix SNP array). There were 150K of SNP
overlapping between the two platforms, so imputation was
performed on the two data sets independently. For Illumina
SNP data, SNP genotype data from unrelated individuals were
phased with Beagle [52] then imputed with Minimac [53] with the
1000 Genomes Project reference [21]. After post-imputation
quality control, there were total imputed 8,064,119 SNPs (MAF of
0.01, r2 of 0.3). For Affymetrix data set, the SNP genotypes of 43
individuals were imputed with SNP data genotyped on Affymetrix
Table 1. The top 10 VMR clusters and their associated genes.
Number of variable CpGs in VMR clusters VMR cluster coordinates Associated genes
53 chr20:57426730–57464571 GNAS, GNAS-AS1
49 chr8:144358566–144371985 GLI4, ZNF696
47 chr7:27143370–27184750 HOXA2, HOXA3, HOXA5, HOXA6, HOXA-AS3
44 chr5:140718989–140863492 PCDHGA1,PCDHGA2,PCDHGA3,PCDHGA4,PCDHGA5,
PCDHGA6,PCDHGA7,PCDHGA8,PCDHGA11,PCDHGB1,
PCDHGB2,PCDHGB3,PCDHGB4,PCDHGB7,PCDHGB8P,
PCDHGC3,PCDHGC4
41 chr20:32255315–32255936 ACTL10,NECAB3
35 chr5:135415001–135416725 VTRNA2-1
28 chr19:57349099–57352134 MIMT1, PEG3, ZIM2
26 chr8:145162974–145164623 KIAA1875, MAF1
26 chr11:7110142–7110456 RBMXL2
24 chr1:205818899–205819600 PM20D1
The genes in bold text expressed at detectible level in whole blood and were selected for association testing.
doi:10.1371/journal.pone.0099313.t001
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SNP array, including 268 pairs, 236 trios, and 926 unrelated
individuals. All Mendel inconsistencies were set to missing before
phased with Beagle to take into account family structure. Then
Minimac was used for imputation. There were 8,022,142 SNPs
after the post-imputation quality control. Approximately
7,800,000 overlapping SNPs between the two imputed data sets
were merged by including only well imputed SNPs on the two data
sets. SNPs with MAF .0.05 and HWE .0.001 were extracted,
and there were 5,257,772 imputed SNPs remained in this study.
Allele-specific methylation
Allele-specific methylation (ASM) analysis was performed as
described [13]. Briefly, we generated the 262 contingency table
where the two columns containing the two alleles and the two rows
containing the counts of methylated and un-methylated cytosines
at CpG site(s) on the read containing heterozygous SNP(s). The p-
value at each CpG site was calculated by Fisher’s exact test. We
identified ASM if the p-value was less than 0.001 and the
methylation frequency between the two alleles was greater than
0.2.
Genomic region annotation
Genomic features of CpG sites were assigned using bedtools
[54] according to genomic annotation structure described by
Bikikova et al, 2011 [35]. The enrichment of CpG sites from
different analyses was calculated as the ratio between significant
CpG sites from each analysis and CpG sites included in the
analysis.
Variation-SNP and variably mathylated regions
We identified vSNPs and VMRs by performing association tests.
Linear regression was performed on the variance of DNA
methylation at each CpG site among individuals and the three
genotype groups (AA, AB, BB) within 1 Mb distance. The t-score of
each CpG-SNP pair was calculated, and the false discovery rate was
calculated by using different cutoff values for the test statistic values.
To deal with the high rate of false positive signals, we required at
least five adjacent CpG sites with maximal spacing 200 bp between
CpGs showing consistent association for VMRs. We then grouped
the overlapping or adjacent VMRs into clusters. We note that
VMRs associated with different vSNPs could be partially overlap-
ping, so they could be grouped into the same cluster.
Accession number
DNA methylation data of this study has been deposited in the
Gene Expression Omnibus (GEO) database under accession
number GSE47614.
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